Close Menu

NEW YORK (GenomeWeb) – Biocept filed a preliminary prospectus with the US Securities and Exchange Commission on Wednesday for an offering of $10 million in shares of its common stock with attached warrants to purchase additional shares.

The company has not yet priced the offering but said that each stock share will be coupled with a warrant to purchase one additional share with an exercise price not less than 100 percent of the last reported sale price of the firm's common stock on the trading day immediately preceding the pricing of the offering.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.